Mimetogen Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Mimetogen Pharmaceuticals General Information

Description

Operator of a clinical-stage biotechnology company intended to focus on the development of peptidomimetics. The company's peptidomimetics focuses on treating dry eye, glaucoma, keratoconus, and retinitis pigmentosa, enabling healthcare providers to treat ophthalmic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1000 de La Gauchetière Street West
  • Suite 2100
  • Montreal, Quebec H3B 4W5
  • Canada
+1 (514)
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Corporate Office
  • 1000 de La Gauchetière Street West
  • Suite 2100
  • Montreal, Quebec H3B 4W5
  • Canada
+1 (514)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mimetogen Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 01-Jan-2018 Completed Clinical Trials - Phase 3
5. Later Stage VC 18-Jul-2013 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series B) 25-Feb-2011 Completed Startup
3. Early Stage VC (Series A) 07-Oct-2009 Completed Startup
2. Seed Round 31-Oct-2005 $848K $848K Completed Startup
1. University Spin-Out 01-Sep-2005 Completed Startup
To view Mimetogen Pharmaceuticals’s complete valuation and funding history, request access »

Mimetogen Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotechnology company intended to focus on the development of peptidomimetics. The company'
Pharmaceuticals
Montreal, Canada
3 As of 2017

South San Francisco, CA
 

Burlington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mimetogen Pharmaceuticals Competitors (18)

One of Mimetogen Pharmaceuticals’s 18 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Cardurion Venture Capital-Backed Burlington, MA
Merck & Co. Corporation Rahway, NJ
Gilead Sciences Formerly VC-backed Foster City, CA
Ability Pharma Private Equity-Backed Barcelona, Spain
You’re viewing 5 of 18 competitors. Get the full list »

Mimetogen Pharmaceuticals Patents

Mimetogen Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190194251-A1 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts Active 09-Jul-2015
US-11078234-B2 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts Active 09-Jul-2015
US-10125165-B2 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts Active 09-Jul-2015
EP-3319978-A1 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts Active 09-Jul-2015
JP-2018528928-A Liquid phase synthesis and crystallization of β-turn peptidomimetic cyclic salts Active 09-Jul-2015 C07K1/02
To view Mimetogen Pharmaceuticals’s complete patent history, request access »

Mimetogen Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mimetogen Pharmaceuticals Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
McGill Dobson Centre for Entrepreneurship Accelerator/Incubator Minority
Schooner Capital Growth/Expansion Minority
Medwell Capital Investment Bank Minority
MSBi Valorisation Venture Capital Minority
Inovia Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Mimetogen Pharmaceuticals FAQs

  • When was Mimetogen Pharmaceuticals founded?

    Mimetogen Pharmaceuticals was founded in 2005.

  • Where is Mimetogen Pharmaceuticals headquartered?

    Mimetogen Pharmaceuticals is headquartered in Montreal, Canada.

  • What is the size of Mimetogen Pharmaceuticals?

    Mimetogen Pharmaceuticals has 3 total employees.

  • What industry is Mimetogen Pharmaceuticals in?

    Mimetogen Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Mimetogen Pharmaceuticals a private or public company?

    Mimetogen Pharmaceuticals is a Private company.

  • What is Mimetogen Pharmaceuticals’s current revenue?

    The current revenue for Mimetogen Pharmaceuticals is .

  • How much funding has Mimetogen Pharmaceuticals raised over time?

    Mimetogen Pharmaceuticals has raised $3.65M.

  • Who are Mimetogen Pharmaceuticals’s investors?

    McGill Dobson Centre for Entrepreneurship, Schooner Capital, Medwell Capital, MSBi Valorisation, and Inovia Capital are 5 of 6 investors who have invested in Mimetogen Pharmaceuticals.

  • Who are Mimetogen Pharmaceuticals’s competitors?

    Genentech, Cardurion, Merck & Co., Gilead Sciences, and Ability Pharma are some of the 18 competitors of Mimetogen Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »